Clinical Trial

Monitoring of Outcomes of Cellular and Exosome-based Therapies in Autoinflammatory and Post-infectious Neuroinflammatory Syndromes

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, non-randomized, observational registry study evaluating the clinical outcomes of patients with autoimmune or post-infectious neuroinflammatory syndromes receiving stem cell-derived biologics (including mesenchymal stem cells and exosomes) at Biocells Medical clinics. The study aims to track improvements in neurological function, inflammatory biomarkers, and patient-reported quality of life following individualized regenerative interventions.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-20.
Trial Details
NCT Number NCT07145502
Lead Sponsor Biocells Medical
Conditions Autoimmune Encephalitis, Early-stage Panencephalitis, Neuroinflammatory Demyelination
Enrollment 76 participants
Start Date 2022-09-19
Primary Completion 2024-07-15 (estimated)
Study Completion 2027-09-19 (estimated)
Updated on ClinicalTrials.gov 2025-09-05